Page 1 | Search Results | Blood | American Society of Hematology

1-18 of 18

Sort by

Sort Order Select

Journal Articles

Trial in Progress: An Open-Label Expansion Trial Evaluating the Safety, PK/PD, and Clinical Activity of Emavusertib (CA-4948) + Ibrutinib in R/R Primary CNS Lymphoma

Christian Grommes, Grzegorz S. Nowakowski, Allison C. Rosenthal, Matthew A Lunning, Radhakrishnan Ramchandren, Lucia Regales, Meaghan Fowle, Maureen Lane, Catherine Wang, Antonio Omuro, Lori A. Leslie, Carole Soussain, Anna Paulina Dabrowska-Iwanicka, Andrés José María Ferreri, Han Tun

Blood (2023) 142 (Supplement 1): 3143.

https://doi.org/10.1182/blood-2023-190391

Published: 2023

Journal Articles

Clinicopathologic Features and Survival Outcomes of Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue (MALT Lymphoma) of the Urothelial Organs (Urologic MALT Lymphoma): The Mayo Clinic Experience (2013-2022)

Ahmad Ghorab, Firas Baidoun, Osama Mosalem, Karan Seegobin, Muhamad Alhaj Moustafa, Han Tun

Blood (2023) 142 (Supplement 1): 3050.

https://doi.org/10.1182/blood-2023-191035

Published: 2023

Journal Articles

The Role of Radiation in Primary Mediastinal Large B-Cell Lymphoma

Firas Baidoun, Bradford Hoppe, Han Tun, Muhamad Alhaj Moustafa

Blood (2023) 142 (Supplement 1): 3106.

https://doi.org/10.1182/blood-2023-189016

Published: 2023

Journal Articles

Outcomes of Neutropenic Patients with Severe Infections Treated with Granulocyte Transfusions: The USC Experience

Graham Blake Parker, Darin Poei, Shirley Ye, Han Tun, Opal Reddy, Raghuveer Ranganathan, Zaw Win Myint

Blood (2023) 142 (Supplement 1): 5564.

https://doi.org/10.1182/blood-2023-188234

Published: 2023

Journal Articles

Takeaim Lymphoma: An Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Combination with Ibrutinib in Patients with Relapsed or Refractory Hematologic Malignancies

Christian Grommes, Han Tun, Allison C. Rosenthal, Matthew A Lunning, Radhakrishnan Ramchandren, Lucia Regales, Wanying Zhao, Maureen Lane, Catherine Wang, Reinhard von Roemeling, Iris Isufi, Lori A. Leslie, Grzegorz S. Nowakowski

Blood (2023) 142 (Supplement 1): 4497.

https://doi.org/10.1182/blood-2023-189746

Published: 2023

Journal Articles

Experience with Gray Zone Lymphoma (GZL) at Mayo Clinic: A Review of Clinical Characteristics and Treatment Outcomes

Ahmad Ghorab, Osama Mosalem, Firas Baidoun, Han Tun, Muhamad Alhaj Moustafa

Blood (2023) 142 (Supplement 1): 6317.

https://doi.org/10.1182/blood-2023-191074

Published: 2023

Journal Articles

Characteristics and Outcomes for Adult Patients with T-Lymphoblastic Leukemia/Lymphoma (T-ALL/LBL): A Retrospective Study

Julian Hardy McLain, Madeline Macdonald, Matthew Juarez, Han Tun, Upama Giri, Maria E. Vergara-Lluri, Imran Siddiqi, Zaw Win Myint

Blood (2022) 140 (Supplement 1): 11588–11589.

https://doi.org/10.1182/blood-2022-170735

Published: 2022

Journal Articles

Time to Diagnosis and Treatment in an Underserved, Predominantly Hispanic Population of Adults in East Los Angeles- a Retrospective Study of Acute T- Lymphoblastic Leukemia/Lymphoma (T-ALL/LBL) Patients

Madeline Macdonald, Matthew Juarez, Julian Hardy McLain, Maria E. Vergara-Lluri, Imran Siddiqi, Upama Giri, Han Tun, Zaw Win Myint

Blood (2022) 140 (Supplement 1): 11598–11599.

https://doi.org/10.1182/blood-2022-158703

Published: 2022

Journal Articles

Phase I Study of First-in-Class Oral Triplet Therapy DTRM-555 in Relapsed/Refractory Lymphoma Patients through Fixed-Dose Combination and Synthetic Lethality

Blood (2018) 132 (Supplement 1): 5384.

https://doi.org/10.1182/blood-2018-99-112944

Published: 2018

Journal Articles

Clinical Outcomes and Cost Analysis of Dose-Adjusted R-EPOCH Vs R-CHOP in Treatment of Diffuse Large B- Cell Lymphoma with High Risk Features

Bhagirathbhai Dholaria, MBBS, Prakash Vishnu, MD, Yenni Alejandro Moreno-Vanegas, Aaron C. Spaulding, Nancy N. Diehl, David Hodge, Candido E. Rivera, MD, Han Tun, MD

Blood (2018) 132 (Supplement 1): 4790.

https://doi.org/10.1182/blood-2018-99-117743

Published: 2018

Journal Articles

Autologous Stem Cell Transplantation for Mantle Cell Lymphoma in the Elderly (≥65 Years Of Age): The Mayo Clinic Experience

Priyanka Pophali, MD, Allison C. Rosenthal, DO, Han Tun, MD, Craig B. Reeder, MD, Ivana N Micallef, MD, Luis Porrata, MD, Stephen M Ansell, MD PhD, Patrick Johnston, MD, David J Inwards, MD

Blood (2017) 130 (Supplement 1): 4536.

https://doi.org/10.1182/blood.V130.Suppl_1.4536.4536

Published: 2017

Journal Articles

Novel Proteasome Inhibitors Induce Mitochondrial Destabilization and Activate Caspase Mediated Apoptosis In Preclinical Models Of Pediatric B-Cell Cancers

Aneel Paulus, MD, MS, Kasyapa S. Chitta, PhD, Eric Sandler, MD, Sharoon Akhtar, Maja Kuranz, Han Tun, MD, Vivek Roy, M.D., James M. Foran, MD, Kena Miller, A.R.N.P, Candido E. Rivera, MD, Asher Chanan-Khan, MD

Blood (2013) 122 (21): 5140.

https://doi.org/10.1182/blood.V122.21.5140.5140

Published: 2013

Journal Articles

Ofatumumab Based Chemoimmunotherapy (CIT) for Patients with Previously Untreated CLL,

Tait D. Shanafelt, MD, Mark C Lanasa, MD, PhD, Clive S. Zent, MD, Jose F. Leis, MD, PhD, Timothy G Call, MD, Betsy R. LaPlant, Han Tun, MD, Deborah A. Bowen, Diane F. Jelinek, Ph.D., Curtis A. Hanson, MD, Neil Kay, MD

Blood (2011) 118 (21): 3898.

https://doi.org/10.1182/blood.V118.21.3898.3898

Published: 2011

Journal Articles

Lenalidomide Consolidation Appears to Prolong Time to Retreatment After First-Line Chemoimmunotherapy for Patients with Previously Untreated CLL,

Tait D. Shanafelt, MD, Han Tun, MD, Curtis A. Hanson, MD, Clive S. Zent, MD, Jose F. Leis, MD, PhD, Timothy G Call, MD, Betsy R. LaPlant, Deborah Bowen, EmilyS S Pavey, Diane F. Jelinek, Ph.D., Neil Kay, MD

Blood (2011) 118 (21): 3899.

https://doi.org/10.1182/blood.V118.21.3899.3899

Published: 2011

Journal Articles

Lendalidomide Consolidation After First-Line Chemoimmunotherapy for Patients with Previously Untreated CLL

Tait Shanafelt, MD, Han Tun, MD, Curtis Hanson, Clive S. Zent, MD, Jose Leis, Timothy Call, MD, Betsy LaPlant, Deborah Bowen, Kristina Laumann, Diane F. Jelinek, PhD, Neil E. Kay

Blood (2010) 116 (21): 1379.

https://doi.org/10.1182/blood.V116.21.1379.1379

Published: 2010

Journal Articles

Melanoma and Non-Melanoma Skin Cancer in Patients with Chronic Lymphocytic Leukemia.

Timothy G Call, MD, Kari G Rabe, MS, Brewer D Jerry, M.D., Neil E. Kay, MD, Clive S. Zent, MD, Susan M Schwager, Deborah A Bowen, FNP, Jose F Leis, MD, Han Tun, MD, Svetomir N Markovic, MD, PhD, Susan L Slager, PhD, Tait D. Shanafelt, M.D.

Blood (2009) 114 (22): 1268.

https://doi.org/10.1182/blood.V114.22.1268.1268

Published: 2009

Journal Articles

Efficacy of Conventional Cytogenetics and FISH for EGR1 To Detect Deletion 5q in Hematological Disorders and To Assess Response to Treatment with Lenalidomide.

Ying Zou, MD, Stephanie Fink, Kimberly Stockero, Sarah Paternoster, Stephanie Smoley, Han Tun, M.D., Craig Reeder, M.D., Ayalew Tefferi, M.D., Gordon Dewald, Ph.D.

Blood (2006) 108 (11): 2351.

https://doi.org/10.1182/blood.V108.11.2351.2351

Published: 2006

Journal Articles

Platelet Count Is a Sensitive Predictor of Bone Marrow Reserve and Autologous Peripheral Blood Progenitor Cell Mobilization.

Abba Zubair, MD, PhD, Rhonda Grant, BSc, Han Tun, MD, Candido Rivera, MD, Alvaro Moreno-aspitia, MD, Vivek Roy, MD, Gerry Colon-Otero, MD, Lawrence Solberg, PhD., MD

Blood (2005) 106 (11): 5280.

https://doi.org/10.1182/blood.V106.11.5280.5280

Published: 2005

NARROW

Trial in Progress: An Open-Label Expansion Trial Evaluating the Safety, PK/PD, and Clinical Activity of Emavusertib (CA-4948) + Ibrutinib in R/R Primary CNS Lymphoma

Clinicopathologic Features and Survival Outcomes of Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue (MALT Lymphoma) of the Urothelial Organs (Urologic MALT Lymphoma): The Mayo Clinic Experience (2013-2022)

The Role of Radiation in Primary Mediastinal Large B-Cell Lymphoma

Outcomes of Neutropenic Patients with Severe Infections Treated with Granulocyte Transfusions: The USC Experience

Takeaim Lymphoma: An Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Combination with Ibrutinib in Patients with Relapsed or Refractory Hematologic Malignancies

Experience with Gray Zone Lymphoma (GZL) at Mayo Clinic: A Review of Clinical Characteristics and Treatment Outcomes

Characteristics and Outcomes for Adult Patients with T-Lymphoblastic Leukemia/Lymphoma (T-ALL/LBL): A Retrospective Study

Time to Diagnosis and Treatment in an Underserved, Predominantly Hispanic Population of Adults in East Los Angeles- a Retrospective Study of Acute T- Lymphoblastic Leukemia/Lymphoma (T-ALL/LBL) Patients

Phase I Study of First-in-Class Oral Triplet Therapy DTRM-555 in Relapsed/Refractory Lymphoma Patients through Fixed-Dose Combination and Synthetic Lethality

Clinical Outcomes and Cost Analysis of Dose-Adjusted R-EPOCH Vs R-CHOP in Treatment of Diffuse Large B- Cell Lymphoma with High Risk Features

Autologous Stem Cell Transplantation for Mantle Cell Lymphoma in the Elderly (≥65 Years Of Age): The Mayo Clinic Experience

Novel Proteasome Inhibitors Induce Mitochondrial Destabilization and Activate Caspase Mediated Apoptosis In Preclinical Models Of Pediatric B-Cell Cancers

Ofatumumab Based Chemoimmunotherapy (CIT) for Patients with Previously Untreated CLL,

Lenalidomide Consolidation Appears to Prolong Time to Retreatment After First-Line Chemoimmunotherapy for Patients with Previously Untreated CLL,

Lendalidomide Consolidation After First-Line Chemoimmunotherapy for Patients with Previously Untreated CLL

Melanoma and Non-Melanoma Skin Cancer in Patients with Chronic Lymphocytic Leukemia.

Efficacy of Conventional Cytogenetics and FISH for EGR1 To Detect Deletion 5q in Hematological Disorders and To Assess Response to Treatment with Lenalidomide.

Platelet Count Is a Sensitive Predictor of Bone Marrow Reserve and Autologous Peripheral Blood Progenitor Cell Mobilization.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only